Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1189-2019Class III

BIOPHEN UFH Control C1, REF 224101

Aniara Diagnostica LLC / initiated 2019-03-19 / Terminated / root cause: labeling and UDI

Aniara Diagnostica LLC began a recall of BIOPHEN UFH Control C1, REF 224101 on . FDA classified it as Class III and gives the reason as "The manufacturer packaged incorrect versions of the Instructions for Use into specific lots for three device product codes". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-1189-2019
Classification
Class III
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Aniara Diagnostica LLC
Product
BIOPHEN UFH Control C1, REF 224101
Product code
GGN Plasma, Coagulation Control
Reason for recall
The manufacturer packaged incorrect versions of the Instructions for Use into specific lots for three device product codes.
Root cause tag
labeling and UDI
FDA root cause
Error in labeling
Action
On March 18, 2019, the recalling firm notified its two affected customers of the recall via email. The email included an attached Urgent Medical Device Correction letter from HYPHEN BioMed, which informed customers that incorrect instructions for use had been packaged into specific lots of three device product codes. Customers were instructed to destroy the incorrect IFUs and begin using the corrected IFUs. Customers were also asked to complete and return customer response forms to Aniara Diagnostica.
Quantity in commerce
41 units
Distribution
Distributed to accounts in MI and PA.
Product codes and lots
Lots F1700314P2, F1700314P3, F1700314P4, F1801638P1

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1189-2019
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1188-2019Class IIITerminatedVoluntary: Firm initiated
Z-1189-2019Class IIITerminatedVoluntary: Firm initiated
Z-1190-2019Class IIITerminatedVoluntary: Firm initiated